Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
MMA Warns Against Corporate Overreach in Malaysian Healthcare
Research & Development MMA Warns Against Corporate Overreach in Malaysian Healthcare

In a landscape where healthcare should prioritize patient well-being above all, the Malaysian Medical Association (MMA) has raised a critical alarm about the increasing influence of corporate entities on medical decisions, threatening the ethical foundation of the profession. As articulated by its

Whole Genome Sequencing Could Transform Breast Cancer Care
Research & Development Whole Genome Sequencing Could Transform Breast Cancer Care

Breast cancer remains a significant global health challenge, affecting millions of lives with its high prevalence and mortality rates, as evidenced by over 2.3 million women diagnosed worldwide in a single year and nearly 670,000 deaths. This alarming reality highlights the urgent need for

Can AI Predict Future Knee X-Rays for Better Osteoarthritis Care?
Tech & Innovation Can AI Predict Future Knee X-Rays for Better Osteoarthritis Care?

What if a glimpse into the future could save millions from the crippling pain of osteoarthritis, a condition affecting over 500 million people worldwide? Picture a tool that shows how a knee joint might look a year from now, revealing the silent progression of this debilitating disease. This isn't

Can Affordable Robots Transform Bioanalytical Labs?
Tech & Innovation Can Affordable Robots Transform Bioanalytical Labs?

In the dynamic realm of bioanalytical research, where precision and efficiency underpin every breakthrough, smaller laboratories often grapple with a significant obstacle: the prohibitive cost of automation technology. These facilities, crucial to pharmaceutical advancements through the meticulous

Wearable Tech Breakthrough Enhances Cough Detection Accuracy
Tech & Innovation Wearable Tech Breakthrough Enhances Cough Detection Accuracy

In a world where chronic respiratory conditions like asthma affect millions, the ability to monitor symptoms in real-time could be a lifeline, and recent advancements in wearable technology are making this a reality with unprecedented precision. Researchers from North Carolina State University (NC

CGT Manufacturing Innovation – Review
Biotech & Bioprocessing CGT Manufacturing Innovation – Review

Imagine a world where life-altering treatments for devastating conditions like glioblastoma or ovarian cancer are not just a scientific breakthrough but are accessible to every patient in need, regardless of location or financial means. This vision, though tantalizingly close in 2025, remains out

Regeneron’s Gene Therapy Breakthrough for Hearing Loss
Research & Development Regeneron’s Gene Therapy Breakthrough for Hearing Loss

I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, particularly in the realm of cutting-edge technologies and innovations in the industry. Today, we’re diving into the groundbreaking world of gene therapy for hearing loss, focusing

Human Disease Blood Atlas Redefines Diagnostic Precision
Tech & Innovation Human Disease Blood Atlas Redefines Diagnostic Precision

Imagine a world where a single blood test could detect cancer, cardiovascular issues, or autoimmune disorders years before symptoms manifest, saving countless lives through early intervention with unprecedented accuracy. This vision is becoming a reality with the emergence of the Human Disease

Prime Editing Breakthroughs: Safety and Delivery Challenges
Biotech & Bioprocessing Prime Editing Breakthroughs: Safety and Delivery Challenges

In the rapidly evolving landscape of genetic medicine, prime editing has emerged as a transformative technology, offering unprecedented precision in correcting DNA mutations that underlie devastating disorders like cystic fibrosis, and it was recently highlighted at an industry gathering in

Post-Trial Access: A Critical Compliance Imperative
Research & Development Post-Trial Access: A Critical Compliance Imperative

In the realm of clinical research, the conclusion of a trial often feels like crossing a finish line, with key milestones such as database lock, the final monitoring visit, or the last patient out signaling closure for sponsors and contract research organizations (CROs). However, for the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later